2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Advances in Cancer Genetics and Genomics

Breakthroughs in cancer genetics and genomics are uncovering the genetic mutations and molecular mechanisms that drive cancer development and progression. These discoveries enable personalized treatment approaches, such as targeted therapies and precision oncology. At the Cancer Research and Development Conference 2025, we will explore how next-generation sequencing and CRISPR-based technologies are accelerating the identification of biomarkers, enhancing early detection, and improving prognostic accuracy. These advances are transforming cancer care, paving the way for more effective and tailored interventions that promise better patient outcomes.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno Oncology and Cell Based Therapies
Innovations in Immuno Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR T Cell Therapy: Clinical Progress and Challenges
Next Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy